Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Albireo Pharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ALBO
Nasdaq
8731
http://www.albireopharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Albireo Pharma Inc
Albireo Presents New Bylvay® (odevixibat) Data at Annual ESPGHAN Congress
- Jun 24th, 2022 12:30 pm
Albireo Announces Presentation of New Data in Pediatric and Adult Liver Diseases
- Jun 23rd, 2022 12:30 pm
Albireo to Present New Data at the EASL International Liver Congress™ 2022
- Jun 8th, 2022 12:30 pm
Albireo to Present New Data at the 54th Annual Meeting of ESPGHAN
- Jun 7th, 2022 12:30 pm
Albireo to Participate at Upcoming Investor Conferences
- Jun 2nd, 2022 8:30 pm
Albireo Presented Data in Cholestatic Liver Diseases at Digestive Disease Week (DDW) 2022
- May 23rd, 2022 12:30 pm
Time To Worry? Analysts Are Downgrading Their Albireo Pharma, Inc. (NASDAQ:ALBO) Outlook
- May 21st, 2022 12:11 pm
Albireo to Participate in the H.C. Wainwright Global Investment Conference 2022
- May 19th, 2022 8:30 pm
Albireo Pharma (ALBO) Reports Q1 Loss, Lags Revenue Estimates
- May 16th, 2022 9:15 pm
Albireo Reports Q1 2022 Financial Results and Business Update
- May 16th, 2022 8:01 pm
Here's What Albireo Pharma, Inc.'s (NASDAQ:ALBO) Shareholder Ownership Structure Looks Like
- May 15th, 2022 12:52 pm
Exelixis (EXEL) Tops Q1 Earnings Estimates
- May 10th, 2022 9:25 pm
Albireo to Report Q1 2022 Financial Results on May 16
- May 9th, 2022 12:30 pm
10 Biotech Stocks to Buy Today According to Kerr Neilson’s Platinum Asset Management
- Apr 20th, 2022 6:25 pm
Investing in Albireo Pharma (NASDAQ:ALBO) five years ago would have delivered you a 57% gain
- Apr 19th, 2022 10:13 am
10 Pharmaceutical Stocks to Buy Now According to Billionaire Kerr Neilson
- Apr 14th, 2022 2:06 pm
Albireo Completes Enrollment in Pivotal Phase 3 ASSERT Study of BylvayTM (odevixibat) in Alagille Syndrome
- Mar 29th, 2022 12:30 pm
Here's Why Albireo Pharma (NASDAQ:ALBO) Can Manage Its Debt Despite Losing Money
- Mar 5th, 2022 12:07 pm
Albireo Pharma (ALBO) Reports Q4 Loss, Tops Revenue Estimates
- Mar 1st, 2022 3:25 pm
Albireo Reports Q4 and Year-End 2021 Financial Results and Business Update
- Mar 1st, 2022 1:30 pm
Scroll